GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Medical System Holdings Ltd (FRA:2M7C) » Definitions » Additional Paid-In Capital

China Medical System Holdings (FRA:2M7C) Additional Paid-In Capital : €265.7 Mil(As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is China Medical System Holdings Additional Paid-In Capital?


China Medical System Holdings's quarterly additional paid-in capital declined from Dec. 2023 (€270.4 Mil) to Jun. 2024 (€259.4 Mil) but then increased from Jun. 2024 (€259.4 Mil) to Dec. 2024 (€265.7 Mil).

China Medical System Holdings's annual additional paid-in capital declined from Dec. 2022 (€285.1 Mil) to Dec. 2023 (€270.4 Mil) and declined from Dec. 2023 (€270.4 Mil) to Dec. 2024 (€265.7 Mil).


China Medical System Holdings Additional Paid-In Capital Historical Data

The historical data trend for China Medical System Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Medical System Holdings Additional Paid-In Capital Chart

China Medical System Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 285.11 270.42 265.70

China Medical System Holdings Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 285.11 271.38 270.42 259.39 265.70

China Medical System Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

China Medical System Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of China Medical System Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


China Medical System Holdings Business Description

Traded in Other Exchanges
Address
510 King’s Road, Unit 2106, 21st Floor, Island Place Tower, North Point, Hong Kong, HKG
China Medical System Holdings Ltd is active in the healthcare segment. It is one of the China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil, Salofalk, Combizym, and others.

China Medical System Holdings Headlines

No Headlines